Parathyroid adenomas are benign neoplasms that are responsible for 80-90% of primary hyperparathyroidism (PHPT) cases. Usually, one out of four parathyroid glands is affected and grows in a clonal fashion [1] . Most adenomas reveal a solid cellular formation and are apparently clonal lesions in histological findings, although some show a heterogeneous cellular component with multiple, often more or less encapsulated nodules [2] . Previous studies using molecular cytogenetic techniques have confirmed that cells of parathyroid adenomas proliferate in monoclonal fashion [1, [3] [4] [5] . Moreover, monoclonal adenoma reportedly can also develop from polyclonal lesions, histo- We have previously demonstrated that elevated RIα expression is associated with diffuseto-nodular transformation of hyperplasia in parathyroid glands of renal hyperparathyroidism. The aim of the current study was to determine whether or not RIα expression is increased in adenomas of primary hyperparathyroidism (PHPT), because monoclonal proliferation has been demonstrated in both adenomas and nodular hyperplasia. Surgical specimens comprising 22 adenomas and 11 normal glands, obtained from 22 patients with PHPT, were analyzed. Western blot and immunohistochemical analyses were employed to evaluate RIα expression. PKA activities were determined in several adenomas highly expressing RIα. RIα expression was also separately evaluated in chief and oxyphilic cells using the "Allred score" system. Expression of proliferating cell nuclear antigen (PCNA), a proliferation marker, was also immunohistochemically examined. Western blot analysis revealed that 5 out of 8 adenomas highly expressed RIα, compared with normal glands. PKA activity in adenomas was significantly less than in normal glands. Immunohistochemical analysis further demonstrated high expression of RIα in 20 out of 22 adenomas. In adenomas, the greater RIα expression and more PCNA positive cells were observed in both chief and oxyphilic cells. The present study suggested that high RIα expression could contribute to monoclonal proliferation of parathyroid cells by impairing the cAMP/PKA signaling pathway.
logically representing a hyperplastic pattern [2] .
To date, two genetic abnormalities responsible for PHPT have been demonstrated [6] . Overexpression of cyclin D1/parathyroid adenomatosis 1 (PRAD1), an important cell cycle regulator, has been shown in 5-40% of sporadic PHPTs [7] [8] [9] . The allelic loss of multiple endocrine neoplasia type 1 (MEN1) tumor suppressor gene accounts for 20-30% of sporadic PHPT [10] [11] [12] . In addition, down-regulation of calcium-sensing and vitamin D receptors is occasionally observed in sporadic PHPT [13] [14] [15] , but these genetic alterations have not been identified [16, 17] . Abnormalities of HRPT2, the gene causing hyperparathyroidism-jaw tumor syndrome (HPT-JT), may be responsible for sporadic parathyroid carcinoma, but rarely for sporadic PHPT [18] .
The PRKAR1A gene encodes for the type Iα regulatory subunit (RIα) of cAMP-dependent protein kinase (PKA). The inactive PKA holoenzyme is a tetramer Submitted Jul. 19, 2012 ; Accepted Oct. 12, 2012 as EJ12-0267 Released online in J-STAGE as advance publication Nov. 29, 2012 Correspondence to: Yatsuka Hibi, M.D., Ph.D., Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan. E-mail: hibichan@fujita-hu.ac.jp ©The Japan Endocrine Society original 22 patients with sporadic PHPT, including 11 pairs of adenomas and adenoma-associated normal glands. The patients underwent a parathyroidectomy procedure at Nagoya University Hospital or Fujita Health University Hospital between 2002 and 2006. Informed consent was obtained from patients for the use of tissue samples to investigate the expression of RIα protein. The investigation protocol was approved by the Ethics Committee, Fujita Health University School of Medicine. Usually one affected gland was resected, but in some cases an additional gland was also resected when it appeared to be enlarged. After operation, most of these glands were found to be normal by histological investigation, and used as a normal gland in this study. Table 1 summarizes the specimens used for this study. The patients did not have a familial history associated with PHPT. Most patients had a single gland disease, as demonstrated by the normal serum calcium level after excision of a histologically-proven parathyroid adenoma.
Human tissue samples
Fresh surgical specimens of 22 patients were composed of two regulatory and two catalytic subunits. Binding of the tetramer with cAMP dissociates the enzyme, releasing a regulatory subunit dimer and two free active catalytic subunits. RIα is ubiquitously expressed, and is the main regulatory subunit of PKA in most cell types [19] . We previously reported that the PRKAR1A gene is frequently overexpressed in nodular hyperplasia cases of hyperparathyroidism associated with chronic renal failure, compared with diffuse hyperplasia cases [20] . Accordingly, PKA activity is significantly suppressed in nodular hyperplasia. In both nodular hyperplasias and PHPT adenomas, the affected cells have been reported to proliferate in a monoclonal fashion [1, 21] . In the present study, we investigate whether RIα protein expression is also altered in PHPT adenomas by measuring specimens obtained from sporadic PHPT patients.
Materials and Methods
Case subjects and materials A total of 33 parathyroid glands were obtained from 
Western blot analysis
Methodological procedures for sample preparation and Western blot analysis were performed as previously described [20] . Mouse monoclonal antibody specific to human RIα (BD Biosciences, Bedford, MA), and rabbit polyclonal antibody specific to glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Sigma-Aldrich, St. Louis, MO) served as primary antibodies. The secondary antibodies were goat polyclonal anti-mouse IgG and anti-rabbit IgG antibodies conjugated to horseradish peroxidase (Sigma-Aldrich). Proteins were visualized by enhanced chemiluminescence reagents. Band densities were quantified using NIH image analysis software (version 1.62, National Institute of Health, Bethesda, MD).
Immunohistochemistry
Immunohistochemistry was performed using the universal immuno-enzyme polymer (UIP) method (ENVISION kit/HRP (DAB); Dako Japan, Tokyo, Japan). According to the manufacturer's instructions, 3-µm thick, paraffin-embedded, tissue sections were mounted on silane-coated slides, followed by deparaffinization and rehydration. Antigen retrieval was achieved by heating the sections three times for 5 min with microwave radiation in 10 mM citrate buffer (pH 6.0). They were then treated with 1% hydrogen peroxide for 5 min to quench endogenous peroxidase activity. The sections were then incubated overnight at 4 o C with mouse monoclonal antibody specific to human RIα (1:1000, BD Biosciences), or rabbit polyclonal antibody specific to human proliferating cell nuclear antigen (PCNA; 1:1000; FL-261, Santa Cruz, Santa Cruz, CA), followed by incubation for 60 min at room temperature with a reagent comprising peroxidase-labeled polymer conjugated to goat anti-rabbit IgG or anti-mouse IgG antibodies. A 3,3'-diaminobenzidine chromogen solution was then applied for 1 min. The sections were then counterstained with hematoxylin, then semi-quantitatively evaluated by light microscopy using the "Allred Score" system [22] . The score represented the estimated proportion of positively stained tumor cells (0 = none, 1 = less than 1/100, 2 = 1/100 to less than 1/10, 3 = 1/10 to less than 1/3, 4 = 1/3 to less than 2/3, and 5 = 2/3 or above). The staining intensities were averaged from the positive cells (0 = none, 1 = weak, 2 = intermediate, and 3 = strong). The sum of these scores served as the total score. A total score between 0 and 2 was considered "low," between 3 and 5 "intermediate," and between 6 and 8 "high." A pathologist with no previous knowledge of the study scored the slides. The slides immunostained with anti-PCNA antibody were also quantitatively evaluated by counting cells displaying positive nuclear staining among 1000 cells detected in 5 randomly selected areas where there was a maximum number of PCNA positive cells.
Determination of PKA activity
PKA activity was measured in tissue lysates (30 µg protein) prepared from adenomas and normal glands using a PKA kinase activity assay kit (StressGen, Ann Arbor, MI). The assay was based on an enzyme-linked immunoabsorbent assay (ELISA) that utilized a specific synthetic peptide as a substrate for PKA and a polyclonal antibody specific to the phosphorylated form of the substrate. PKA activity specificity was ensured by measuring activities in the presence of a PKA inhibitor. PKA activities were determined in the presence and absence of 2 µM cAMP, and represented total and free PKA activity in tissues, respectively.
Statistical analysis
Statistical analysis was performed by Student's t-test, and a P value < 0.05 was considered to be significant.
results

High expression of RIα in PHP adenomas
RIα expression was evaluated by Western blot analysis, using 8 pairs of tissue lysates prepared from adenomas and normal glands. As shown in Fig. 1 , a single, 49-kD, RIα band was detected. Five out of 8 adenomas (Case 1, 2, 4-6) exhibited increased RIα expression in adenomas, compared with the normal glands. However, Case 7 and 8 presented with decreased RIα expression. The lack of GAPDH expression in the normal gland of Case 3 was most likely due to protein degradation during preparation.
The functional significance of high RIα expression in adenomas was evaluated by measuring PKA activity in tissue lysates prepared from adenomas and normal glands (Case 1-6). Free PKA activity was measured in the absence of 2 µM cAMP, and was normalized by total PKA activity measured in the presence of 2 µM cAMP. In Case 7 and 8, since protein sample was not sufficient for PKA activity measurement after use for Western blot analysis, PKA activity measurement could not be performed. The individual values are displayed in Fig. 2A . As shown in Fig. 2B , The ratio of free to total PKA activity in adenomas was significantly less than in normal glands (0.24±0.18 vs. 0.63±0.18; Mean ± SD, p<0.05).
RIα expression was also immunohistochemically analyzed on 22 adenomas and 11 normal glands. Representative images are shown in Fig. 3 . In the adenomas (Fig. 3A) , most parenchymal cells were uniformly stained, which clearly indicated cytoplasmic distribution of RIα protein. In contrast, RIα was weakly stained in the normal gland (Fig. 3B) . Immunostained slides were then semi-quantitatively evaluated using the "Allred Score" system. The individual scores are displayed in Fig. 3C . As shown in Fig. 3D , adenomas presented with a significantly higher average RIα staining score, compared with the normal glands (6.86±0.09 vs. 3.36±2.58; Mean ± SD, p<0.05). The proportion, intensity, and total scores of individual specimens are summarized in Table 1 . Most adenomas (20 out of 22) exhibited a "high" score (Allred score 6-8), while only 2/11 normal glands exhibited a "high" score.
Negative correlation between RIα staining scores and
PKA activity
A possible correlation between the RIα staining scores and Free/total PKA activity ratio (PKA activity) adenomas, were subjected to Western blot analysis using anti-RIα and anti-GAPDH antibodies. Band densities were measured, and RIα expression was normalized according to GAPDH expression. Normalized levels of RIα expression in adenomas were divided by expression in normal glands (A/N ratio), as depicted at the bottom of the image. n.d.: not determined. from 6 adenomas and 6 normal glands was investigated.
There was a significant negative correlation between R1α expression and PKA activity (y=-0.055x+0.704, R²=0.346, p=0.035), reflecting the role of RIα to suppress PKA activity.
Positive correlation between adenoma RIα staining scores and pre-operative serum levels of intact PTH The adenoma RIα staining scores and pre-operative serum levels of intact PTH, normalized by adenoma weights, were plotted to investigate a possible correlation between RIα expression and PTH production. As shown in Fig. 4 , there was a significant positive correlation between the two parameters (y=0.120x-0.446, R²=0.282, p=0.013), suggesting that RIα expression correlated with a hyperfunctional adenoma phenotype. Immunostained slides were semi-quantitatively evaluated using the "Allred Score" system. Data from individual specimens are summarized in Table 1 . The values are plotted in Panel C. The mean value in adenomas was significantly higher than in normal glands (6.86±0.99 vs. 3.36±2.58; mean ± SD; n=22, adenoma; n=11, normal gland; *: p <0.05 vs. normal; Panel D).
Fig. 4
RIα expression in adenomas positively correlated with pre-operative serum levels of intact PTH. Allred scores of RIα expression from 21 adenomas, as well as preoperative serum levels of intact PTH, were normalized by adenoma weights, and were plotted and compared using the linear regression analysis (y=0.120x-0.446, R²=0.282, p =0.013). Data from individual specimens are summarized in Table 1 .
High RIα and PCNA expression in both chief and oxyphilic adenoma cells
According to the immunohistochemical analysis, many adenomas contained clusters of oxyphilic cells (Fig. 5A) . The estimated composition of oxyphilic cells in each adenoma is displayed in Table 1 . Adenomas from Cases 14 and 18 were determined to be "oxyphil adenomas," which contained > 90% oxyphilic cells [23] . To determine the difference between RIα expression in chief and oxyphilic cells, the RIα staining scores were separately analyzed. The individual scores are depicted in Fig. 5B . As shown in Fig. 5C , the RIα expression in both chief and oxyphilic cell adenoma populations was significantly higher than in chief cells of normal glands (p <0.05). PCNA immunohistochemistry staining was performed to identify proliferating cells. As shown in Fig. 6A , some chief and oxyphilic cell nuclei were PCNA-positive. PCNA-positive cells were separately counted in chief and oxyphilic cell populations and the individual values were depicted in 
discussion
The present study demonstrated elevated RIα expression in PHPT adenomas. Previous studies have reported elevated RIα expression in a variety of tumors, such as breast, renal, colorectal, and ovarian cancers, as well as retinoblastoma [24, 25] , which correlated with a worse patient prognosis in these cancer patients. Elevated expression has also been reported in several human cancer cell lines [25] . Increased intracellular RIα levels were shown to promote G1 to S cell cycle transition [26, 27] . Furthermore, RIα expression inhibition by antisense oligodeoxynucleotide resulted in growth arrest and/or apoptosis of several cancer cell lines [28] . In addition, RIα antisense oligodeoxynucleotide inactivated the anti-apoptotic protein bcl-2 via PKA activation [24, 29, 30] . Apart from inhibition of the PKA catalytic subunit, RIα function was also reported [31] . Specifically, RIα is directly bound to cytochrome oxidase, and RIα inhibition results in cytochrome c release and apoptosis. These reports strongly suggest that elevated RIα expression could trigger cell cycle progression and apoptosis suppression. Paradoxically, inactivation of RIα results in the Carney Complex (CNC) [32, 33] , which is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumors, and schwannomas [34, 35] . Endocrine tumors are often multiple. It could be speculated that PKA activity is strictly controlled in normal cells and subtle dysregulation of PKA activity could, therefore, result in tumorigenesis [36, 37] . The oncogenic effects of altered RIα expression might depend upon the cell types. Although the cAMP/PKA pathway plays an important role in proliferation, differentiation, and oncogenic transformation of various cells, little is known about the role of this pathway in parathyroid cell proliferation. Further studies are required to elucidate these mechanisms.
In endocrine organs, in particular parathyroid glands, oxyphilic cells appear and increase with age. The oxyphilic cells in parathyroid glands are thought to be functionally inactive for PTH production [23] . However, it has been reported that, in hyperfunctional adenomas, oxyphilic cells synthesize and secrete PTH [38] . However, the molecular basis for this phenotype change remains obscure. Consistent with this report, the present study demonstrated that the preoperative serum levels of intact PTH are elevated in adenomas that consist primarily of oxyphilic cells (Table 1) . Furthermore, in adenomas, oxyphilic cells, as well as chief cells, express high levels of RIα. In addition, many PCNA-positive cells were detected in chief and oxyphilic adenoma cell populations. These results strongly suggest that elevated RIα expression is involved in the tumorigenesis of oxyphilic cells, as well as chief cells.
In conclusion, while our previous results showed that RIα is also highly expressed in nodular hyperplasia of hyperparathyroidism associated with chronic renal failure [20] , the present results suggest that dysregulated, elevated RIα expression could contribute to monoclonal proliferation of parathyroid cells by impairing the cAMP/PKA signaling pathway.
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